Adjuvant chemotherapy in colon cancer: Ageism or appropriate care?

Journal of Clinical Oncology

Volumn 29, Issue 24, 2011, Pages 3209-3210

  Hubbard, Joleen ^a   Jatoi, Aminah ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; FLUOROPYRIMIDINE; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

AGEISM; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURVIVAL; COLON CANCER; DISEASE FREE SURVIVAL; EDITORIAL; HUMAN; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PATIENT CARE; PRIORITY JOURNAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; FLUOROURACIL; HUMANS; MALE; ORGANOPLATINUM COMPOUNDS;

EID: 80051955660     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.35.8630     Document Type: Editorial

References (17)

1. Moertel C.G., Fleming T.R., Macdonald J.S., et al: Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 322:352-358, 1990
2. André T., Boni C., Mounedji-Boudiaf L., et al: Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350:2343-2351,
3. André T., Boni C., Navarro M., et al: Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol 27:3109-3116, 2009
4. Kuebler J.P., Wieand H.S., O'Connell M.J., et al: Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: Results from NSABP C-07. J Clin Oncol 25:2198-2204, 2007
5. Haller D.G., Tabernero J., Maroun J., et al: Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer. J Clin Oncol 29:1465-1471, 2011
6. http://www.nccn.org/index.asp; last accessed May 2, 2011
7. Abrams T.A., Brightly R., Mao J., et al: Patterns of adjuvant chemotherapy use in a population-based cohort of patients with resected stage II or III colon cancer. J Clin Oncol 29:3255-3262, 2011
8. Jatoi A., Hillman S., Stella P., et al: Should elderly non-small-cell lung cancer patients be offered elderly-specific trials? Results of a pooled analysis from the North Central Cancer Treatment Group. J Clin Oncol 23:9113-9119, 2005
9. ClinicalTrials.gov: Combination chemotherapy plus bevacizumab with or without oxaliplatin in treating older patients with metastatic colorectal cancer. http://www.clinicaltrials.gov/ct2/show/NCT01279681?term
10. Sargent D.J., Goldberg R.M., Jacobson S.D., et al: A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med 345:1091-1097, 2001
11. Sundararajan V., Mitra N., Jacobson J.S., et al: Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with nodepositive colon cancer. Ann Intern Med 136:349-357, 2002
12. Jessup J.M., Steward A., Greene F.L., et al: Adjuvant chemotherapy for stage III colon cancer: Implications of race/ethnicity, age, and differentiation. JAMA 294:2703-2711, 2005
13. Jackson McCleary N.A., Meyerhardt J., Green GY, E, et al: Impact of older age on the efficacy of newer adjuvant therapies in > 12,500 patients (pts) with stage II/III colon cancer: Findings from the ACCENT Database. J Clin Oncol 27:170s, 2009 (suppl; abstr 4010)
14. Hsiao F.S., Mullins C.D., Onukwugha E., et al: Relative survival of adjuvant chemotherapy using 5-FU/LV alone, oxaliplatin, or irinotecan-based combination regimens among stage III colon cancer patients age 65 and older: An analysis using SEER-Medicare data. Presented at the 2010 Gastrointestinal Cancers Symposium, Orlando, FL, January 22-24, 2010 (abstr 30)
15. Schild S.E., Stella P.J., Geyer S.M., et al: The outcome of combined modality therapy for stage III non-small-cell lung cancer in the elderly. J Clin Oncol 21:3201-3206, 2003
16. Jatoi A., Foster N.R., Egner J.R., et al: Older versus younger patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and stomach: A pooled analysis of eight consecutive North Central Cancer Treatment Group (NCCTG) trials. Int J Oncol 36:601-606, 2010
17. Levitz J.S., Lichtman SM: Adjuvant therapy for colon cancer in the elderly: Treat or don't treat? Commun Oncol 2:331-336, 2005